| Year |
Citation |
Score |
| 2022 |
Biggane JP, Xu K, Goldenstein BL, Davis KL, Luger EJ, Davis BA, Jurgens CWD, Perez DM, Porter JE, Doze VA. Pharmacological characterization of the α-adrenergic receptor inhibiting rat hippocampal CA3 epileptiform activity: comparison of ligand efficacy and potency. Journal of Receptor and Signal Transduction Research. 1-8. PMID 35984443 DOI: 10.1080/10799893.2022.2110896 |
0.651 |
|
| 2011 |
Doze VA, Papay RS, Goldenstein BL, Gupta MK, Collette KM, Nelson BW, Lyons MJ, Davis BA, Luger EJ, Wood SG, Haselton JR, Simpson PC, Perez DM. Long-term α1A-adrenergic receptor stimulation improves synaptic plasticity, cognitive function, mood, and longevity. Molecular Pharmacology. 80: 747-58. PMID 21791575 DOI: 10.1124/Mol.111.073734 |
0.563 |
|
| 2009 |
Goldenstein BL, Nelson BW, Xu K, Luger EJ, Pribula JA, Wald JM, O'Shea LA, Weinshenker D, Charbeneau RA, Huang X, Neubig RR, Doze VA. Regulator of G protein signaling protein suppression of Galphao protein-mediated alpha2A adrenergic receptor inhibition of mouse hippocampal CA3 epileptiform activity. Molecular Pharmacology. 75: 1222-30. PMID 19225179 DOI: 10.1124/Mol.108.054296 |
0.733 |
|
| 2008 |
Luger E, Davis K, Goldenstein B, Nelson B, Xu K, Pribula J, Wald J, Weinshenker D, Doze V. Alpha2A adrenergic receptor‐mediated inhibition of mouse hippocampal CA3 network activity The Faseb Journal. 22: 98-98. DOI: 10.1096/Fasebj.22.2_Supplement.98 |
0.649 |
|
| 2007 |
Jurgens CW, Hammad HM, Lichter JA, Boese SJ, Nelson BW, Goldenstein BL, Davis KL, Xu K, Hillman KL, Porter JE, Doze VA. Alpha2A adrenergic receptor activation inhibits epileptiform activity in the rat hippocampal CA3 region. Molecular Pharmacology. 71: 1572-81. PMID 17341653 DOI: 10.1124/Mol.106.031773 |
0.523 |
|
| Show low-probability matches. |